Impact of renal cell carcinoma molecular subtypes on immunotherapy and targeted therapy outcomes

Renée Maria Saliby; Chris Labaki; Tejas R. Jammihal; Wanling Xie; Maxine Sun; Valisha Shah; Eddy Saad; M. Harry Kane; Soki Kashima; Katherine Sadak; Talal El Zarif; Deepak Poduval; Robert J. Motzer; Thomas Powles; Brian I. Rini; Laurence Albiges; Sumanta K. Pal; Bradley A. McGregor; Rana R. McKay; Sabina Signoretti; Eliezer M. Van Allen; Sachet A. Shukla; Toni K. Choueiri; David A. Braun

doi:10.1016/j.ccell.2024.03.002

Impact of renal cell carcinoma molecular subtypes on immunotherapy and targeted therapy outcomes

Renée Maria Saliby, Chris Labaki, Tejas R. Jammihal, Wanling Xie, Maxine Sun, Valisha Shah, Eddy Saad, M. Harry Kane, Soki Kashima, Katherine Sadak, Talal El Zarif, Deepak Poduval, Robert J. Motzer, Thomas Powles, Brian I. Rini, Laurence Albiges, Sumanta K. Pal, Bradley A. McGregor, Rana R. McKay, Sabina SignorettiEliezer M. Van Allen, Sachet A. Shukla, Toni K. Choueiri, David A. Braun

Research output: Contribution to journal › Letter › peer-review

20 Citations (Scopus)

Original language	English
Pages (from-to)	732-735
Number of pages	4
Journal	Cancer Cell
Volume	42
Issue number	5
DOIs	https://doi.org/10.1016/j.ccell.2024.03.002
Publication status	Published - 13 May 2024

Access to Document

10.1016/j.ccell.2024.03.002

Cite this

Saliby, R. M., Labaki, C., Jammihal, T. R., Xie, W., Sun, M., Shah, V., Saad, E., Kane, M. H., Kashima, S., Sadak, K., El Zarif, T., Poduval, D., Motzer, R. J., Powles, T., Rini, B. I., Albiges, L., Pal, S. K., McGregor, B. A., McKay, R. R., ... Braun, D. A. (2024). Impact of renal cell carcinoma molecular subtypes on immunotherapy and targeted therapy outcomes. Cancer Cell, 42(5), 732-735. https://doi.org/10.1016/j.ccell.2024.03.002

@article{2afbc78c1f9649c18b79530e652a8477,

title = "Impact of renal cell carcinoma molecular subtypes on immunotherapy and targeted therapy outcomes",

author = "Saliby, {Ren{\'e}e Maria} and Chris Labaki and Jammihal, {Tejas R.} and Wanling Xie and Maxine Sun and Valisha Shah and Eddy Saad and Kane, {M. Harry} and Soki Kashima and Katherine Sadak and {El Zarif}, Talal and Deepak Poduval and Motzer, {Robert J.} and Thomas Powles and Rini, {Brian I.} and Laurence Albiges and Pal, {Sumanta K.} and McGregor, {Bradley A.} and McKay, {Rana R.} and Sabina Signoretti and {Van Allen}, {Eliezer M.} and Shukla, {Sachet A.} and Choueiri, {Toni K.} and Braun, {David A.}",

year = "2024",

month = may,

day = "13",

doi = "10.1016/j.ccell.2024.03.002",

language = "English",

volume = "42",

pages = "732--735",

journal = "Cancer Cell",

issn = "1535-6108",

number = "5",

}

Saliby, RM, Labaki, C, Jammihal, TR, Xie, W, Sun, M, Shah, V, Saad, E, Kane, MH, Kashima, S, Sadak, K, El Zarif, T, Poduval, D, Motzer, RJ, Powles, T, Rini, BI, Albiges, L, Pal, SK, McGregor, BA, McKay, RR, Signoretti, S, Van Allen, EM, Shukla, SA, Choueiri, TK & Braun, DA 2024, 'Impact of renal cell carcinoma molecular subtypes on immunotherapy and targeted therapy outcomes', Cancer Cell, vol. 42, no. 5, pp. 732-735. https://doi.org/10.1016/j.ccell.2024.03.002

TY - JOUR

T1 - Impact of renal cell carcinoma molecular subtypes on immunotherapy and targeted therapy outcomes

AU - Saliby, Renée Maria

AU - Labaki, Chris

AU - Jammihal, Tejas R.

AU - Xie, Wanling

AU - Sun, Maxine

AU - Shah, Valisha

AU - Saad, Eddy

AU - Kane, M. Harry

AU - Kashima, Soki

AU - Sadak, Katherine

AU - El Zarif, Talal

AU - Poduval, Deepak

AU - Motzer, Robert J.

AU - Powles, Thomas

AU - Rini, Brian I.

AU - Albiges, Laurence

AU - Pal, Sumanta K.

AU - McGregor, Bradley A.

AU - McKay, Rana R.

AU - Signoretti, Sabina

AU - Van Allen, Eliezer M.

AU - Shukla, Sachet A.

AU - Choueiri, Toni K.

AU - Braun, David A.

PY - 2024/5/13

Y1 - 2024/5/13

UR - http://www.scopus.com/inward/record.url?scp=85192225592&partnerID=8YFLogxK

U2 - 10.1016/j.ccell.2024.03.002

DO - 10.1016/j.ccell.2024.03.002

M3 - Letter

C2 - 38579722

AN - SCOPUS:85192225592

SN - 1535-6108

VL - 42

SP - 732

EP - 735

JO - Cancer Cell

JF - Cancer Cell

IS - 5

ER -

Impact of renal cell carcinoma molecular subtypes on immunotherapy and targeted therapy outcomes

Access to Document

Other files and links

Cite this